PacBio
PacBio's mission is to enable the potential of genomics to improve human health by creating the world’s most advanced sequencing systems to provide the most complete and accurate view of genomes, transcriptomes and epigenomes.
Latest Content
Article
Computational Tool To Map Paralogous Genes and Copy Number Variation
Paraphase – a computational tool that accurately resolves and analyzes paralogous genes – unlocks the difficult-to-analyze regions of the genome, providing deeper insights into genetic variation, disease mechanisms and population diversity.
Product News
First Effort To Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand
Thailand is launching Asia’s first newborn genome screening pilot using PacBio HiFi whole genome sequencing.
Product News
PacBio Announces Plans To Improve Methylation Detection in HiFi Chemistry
PacBio enhances HiFi sequencing with AI-based methylation detection, enabling accurate native 5hmC and strand-specific 5mC analysis.
Industry Insight
How SPRQ Chemistry Is Breaking Barriers in DNA Sequencing
Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.
Product News
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing To Help Advance Rare Disease Diagnostics
PacBio (NASDAQ: PACB), announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics.
Product News
PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
PacBio (NASDAQ: PACB), announced the Vega™ system, the company’s first benchtop long-read sequencing platform.
Product News
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to Less Than $500
New long-read sequencing chemistry reduces DNA input requirements four-fold, enables a 33% increase in data output per SMRT cell, improves methylation calling, and expands support for multiomics.
Product News
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program
PacBio (Nasdaq: PACB), announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program.
Product News
Revio To Power Research in Male Infertility and Rare Disease at Münster University Hospital
Highly accurate long-read sequencing data from Revio will support Germany’s national genome Initiative and provide data to the international male infertility consortium.
Product News
Novogene To Power Cancer, Rare Disease, and Environmental Research With PacBio Sequencing
Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions.
Advertisement
